|
3P5T
CFIm25-CFIm68 complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
80–161(82 aa)
Fragment:UNP residues 80-161
Chain M
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;283 K;16% PEG 3350, 5% dioxane, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K
|
Resolution 2.70 Å
R-free 0.265
|
|
3P5T
CFIm25-CFIm68 complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain N
80–161(82 aa)
Fragment:UNP residues 80-161
Chain O
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;283 K;16% PEG 3350, 5% dioxane, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K
|
Resolution 2.70 Å
R-free 0.265
|
|
3P5T
CFIm25-CFIm68 complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
80–161(82 aa)
Fragment:UNP residues 80-161
Chain Q
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;283 K;16% PEG 3350, 5% dioxane, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 283K
|
Resolution 2.70 Å
R-free 0.265
|
|
3P6Y
CF Im25-CF Im68-UGUAA complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain C
80–161(82 aa)
Fragment:UNP residues 80-161
Chain D
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;283 K;15% PEG 3350, 9% dioxane and 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 283K
|
Resolution 2.90 Å
R-free 0.275
|
|
3P6Y
CF Im25-CF Im68-UGUAA complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–RNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain G
80–161(82 aa)
Fragment:UNP residues 80-161
Chain H
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;283 K;15% PEG 3350, 9% dioxane and 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 283K
|
Resolution 2.90 Å
R-free 0.275
|
|
3P6Y
CF Im25-CF Im68-UGUAA complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein–RNA
Heteromer;Protein × 4
PDB declaration: pentameric
|
Chain K
80–161(82 aa)
Fragment:UNP residues 80-161
Chain L
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;283 K;15% PEG 3350, 9% dioxane and 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 283K
|
Resolution 2.90 Å
R-free 0.275
|
|
3P6Y
CF Im25-CF Im68-UGUAA complex
Deposited 2010-10-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein–RNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain O
80–161(82 aa)
Fragment:UNP residues 80-161
Chain P
80–161(82 aa)
Fragment:UNP residues 80-161
|
Mutation:C159S
Mutation:C159S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;283 K;15% PEG 3350, 9% dioxane and 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 283K
|
Resolution 2.90 Å
R-free 0.275
|
|
3Q2S
Crystal Structure of CFIm68 RRM/CFIm25 complex
Deposited 2010-12-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
13–235(223 aa)
Fragment:RRM domain, residues 13-235
Chain D
13–235(223 aa)
Fragment:RRM domain, residues 13-235
|
Mutation:C159V
Mutation:C159V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;20% PEG 3350, 0.2M Magnesium Formate, 0.05M HEPES pH 7.0, vapor diffusion, hanging drop, temperature 298K
|
Resolution 2.90 Å
R-free 0.278
|
|
3Q2T
Crystal Structure of CFIm68 RRM/CFIm25/RNA complex
Deposited 2010-12-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain C
13–235(223 aa)
Fragment:RRM domain, residues 13-235
Chain D
13–235(223 aa)
Fragment:RRM domain, residues 13-235
|
Mutation:C159V
Mutation:C159V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;20% PEG 3350, 0.2M Magnesium Formate, 0.05M HEPES pH 7.0, vapor diffusion, hanging drop, temperature 298K
|
Resolution 3.06 Å
R-free 0.286
|
|
4U0A
Hexameric HIV-1 CA in complex with CPSF6 peptide, P6 crystal form
Deposited 2014-07-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: Dodecameric
|
Chain B
276–290(15 aa)
Fragment:UNP residues 313-327
|
Not recorded
|
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;0.6M sodium potassium tartrate tetrahydrate, 0.1M TRIS
|
Resolution 2.05 Å
R-free 0.253
|
|
4U0B
Hexamer HIV-1 CA in complex with CPSF6 peptide, P212121 crystal form
Deposited 2014-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: Dodecameric
|
Chain M
276–290(15 aa)
Fragment:UNP residues 276-290
Chain N
276–290(15 aa)
Fragment:UNP residues 276-290
Chain O
276–290(15 aa)
Fragment:UNP residues 276-290
Chain P
276–290(15 aa)
Fragment:UNP residues 276-290
Chain Q
276–290(15 aa)
Fragment:UNP residues 276-290
Chain R
276–290(15 aa)
Fragment:UNP residues 276-290
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;20% v/v PEG 300, 10% v/v glycerol, 5% w/v PEG 8K, 0.1 M TRIS
|
Resolution 2.80 Å
R-free 0.262
|
|
4U0B
Hexamer HIV-1 CA in complex with CPSF6 peptide, P212121 crystal form
Deposited 2014-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: Dodecameric
|
Chain S
276–290(15 aa)
Fragment:UNP residues 276-290
Chain T
276–290(15 aa)
Fragment:UNP residues 276-290
Chain U
276–290(15 aa)
Fragment:UNP residues 276-290
Chain V
276–290(15 aa)
Fragment:UNP residues 276-290
Chain W
276–290(15 aa)
Fragment:UNP residues 276-290
Chain X
276–290(15 aa)
Fragment:UNP residues 276-290
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;290 K;20% v/v PEG 300, 10% v/v glycerol, 5% w/v PEG 8K, 0.1 M TRIS
|
Resolution 2.80 Å
R-free 0.262
|
|
4WYM
Structural basis of HIV-1 capsid recognition by CPSF6
Deposited 2014-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain M
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain N
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain O
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain P
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain Q
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain R
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;0.1 M sodium formate, ammonium acetate, tri-sodium citrate, sodium/potassium tartrate, sodium oxamate; 0.1 M sodium HEPES, MOPS; 30% glycerol, PEG 4000
|
Resolution 2.60 Å
R-free 0.259
|
|
4WYM
Structural basis of HIV-1 capsid recognition by CPSF6
Deposited 2014-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain S
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain T
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain U
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain V
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
Chain W
313–327(15 aa)
Fragment:UNP RESIDUES 313-327
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;0.1 M sodium formate, ammonium acetate, tri-sodium citrate, sodium/potassium tartrate, sodium oxamate; 0.1 M sodium HEPES, MOPS; 30% glycerol, PEG 4000
|
Resolution 2.60 Å
R-free 0.259
|
|
6AY9
Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide
Deposited 2017-09-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
276–287(12 aa)
Fragment:UNP residues 276-287
|
Not recorded
|
IOD IODIDE ION × 36
CL CHLORIDE ION × 24
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.50 Å
R-free 0.273
|
|
6GX9
Crystal structure of the TNPO3 - CPSF6 RSLD complex
Deposited 2018-06-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
408–477(70 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
BCN BICINE × 1
BEN BENZAMIDINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;12.8% PEG MME 500, 6.4% PEG 20,000, 4% 1,6-hexandiol, 1.5% benzamidine, 75 mM NaCl, 40 mM MgCl2, 6 mM DTT, 80 mM Tris-bicine, pH 8.0
|
Resolution 2.70 Å
R-free 0.248
|
|
6GX9
Crystal structure of the TNPO3 - CPSF6 RSLD complex
Deposited 2018-06-26
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
408–477(70 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
BCN BICINE × 1
BEN BENZAMIDINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;291 K;12.8% PEG MME 500, 6.4% PEG 20,000, 4% 1,6-hexandiol, 1.5% benzamidine, 75 mM NaCl, 40 mM MgCl2, 6 mM DTT, 80 mM Tris-bicine, pH 8.0
|
Resolution 2.70 Å
R-free 0.248
|
|
7ZUD
Crystal structure of HIV-1 capsid IP6-CPSF6 complex
Deposited 2022-05-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain M
276–288(13 aa)
|
Not recorded
|
IHP INOSITOL HEXAKISPHOSPHATE × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.3M Calcium chloride dihydrate, 0.3 M Magnesium chloride hexahydrate, 0.1 M Tris hydrochloride pH 8.5, 0.1 M Bicine, 20% PEG 4000
|
Resolution 2.93 Å
R-free 0.336
|
|
8CL1
HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to CPSF6 peptide.
Deposited 2023-02-16
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
276–290(15 aa)
Fragment:UNP residues 313-327
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.35 Å
|
|
8EJL
Structure of HIV-1 capsid declination in complex with CPSF6-FG peptide
Deposited 2022-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 30
PDB declaration: 30-meric
|
Chain Y
313–327(15 aa)
Fragment:UNP residues 313-327
Chain Z
313–327(15 aa)
Fragment:UNP residues 313-327
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE;Manual plunge-freezing
|
Resolution 3.90 Å
|
|
8EJL
Structure of HIV-1 capsid declination in complex with CPSF6-FG peptide
Deposited 2022-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain Y
313–327(15 aa)
Fragment:UNP residues 313-327
Chain Z
313–327(15 aa)
Fragment:UNP residues 313-327
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE;Manual plunge-freezing
|
Resolution 3.90 Å
|
|
8EJL
Structure of HIV-1 capsid declination in complex with CPSF6-FG peptide
Deposited 2022-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain Y
313–327(15 aa)
Fragment:UNP residues 313-327
Chain Z
313–327(15 aa)
Fragment:UNP residues 313-327
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE;Manual plunge-freezing
|
Resolution 3.90 Å
|
|
9CNV
HIV-2 CA hexamer bound with CPSF6 peptide; assembled via liposome templating
Deposited 2024-07-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
313–327(15 aa)
|
Mutation:Delta(1-312) and Delta(328-358)
|
IHP INOSITOL HEXAKISPHOSPHATE × 12
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;The mixed buffer of storage buffer for the protein and lipid components with IP6 supplemented.
cryo-EM vitrification conditions
Cryogen ETHANE;Grids were dual-side blotted with blot force 0 for 5.5 sec before plunge freezing in liquid ethane.
|
Resolution 3.16 Å
|
|
9CNV
HIV-2 CA hexamer bound with CPSF6 peptide; assembled via liposome templating
Deposited 2024-07-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
313–327(15 aa)
|
Mutation:Delta(1-312) and Delta(328-358)
|
IHP INOSITOL HEXAKISPHOSPHATE × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;The mixed buffer of storage buffer for the protein and lipid components with IP6 supplemented.
cryo-EM vitrification conditions
Cryogen ETHANE;Grids were dual-side blotted with blot force 0 for 5.5 sec before plunge freezing in liquid ethane.
|
Resolution 3.16 Å
|